23andMe Holding Co. (NASDAQ:ME – Get Free Report) was down 2.3% during trading on Friday . The stock traded as low as $0.30 and last traded at $0.30. Approximately 1,250,183 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 5,377,226 shares. The stock had previously closed at $0.31.
Wall Street Analyst Weigh In
Separately, TD Cowen cut 23andMe from a “strong-buy” rating to a “strong sell” rating in a research report on Wednesday, August 7th.
Read Our Latest Research Report on 23andMe
23andMe Stock Performance
23andMe (NASDAQ:ME – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.14) earnings per share for the quarter. 23andMe had a negative return on equity of 83.22% and a negative net margin of 317.03%. The firm had revenue of $40.41 million for the quarter, compared to analyst estimates of $50.30 million.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of 23andMe by 58.0% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 61,167 shares of the company’s stock worth $56,000 after acquiring an additional 22,460 shares during the period. Wittenberg Investment Management Inc. lifted its stake in 23andMe by 22.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 1,397,393 shares of the company’s stock worth $1,277,000 after purchasing an additional 252,909 shares during the period. Mirador Capital Partners LP lifted its stake in 23andMe by 11.2% during the first quarter. Mirador Capital Partners LP now owns 340,946 shares of the company’s stock worth $181,000 after purchasing an additional 34,321 shares during the period. China Universal Asset Management Co. Ltd. boosted its holdings in 23andMe by 68.3% during the first quarter. China Universal Asset Management Co. Ltd. now owns 60,653 shares of the company’s stock valued at $32,000 after purchasing an additional 24,604 shares in the last quarter. Finally, Levin Capital Strategies L.P. bought a new position in shares of 23andMe during the second quarter valued at $61,000. 36.10% of the stock is owned by institutional investors.
23andMe Company Profile
23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.
Featured Articles
- Five stocks we like better than 23andMe
- ETF Screener: Uses and Step-by-Step Guide
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- How to Invest in the Best Canadian Stocks
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- Stock Market Sectors: What Are They and How Many Are There?
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for 23andMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23andMe and related companies with MarketBeat.com's FREE daily email newsletter.